Nabaltec AG (NTG)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 10.85 |
|---|---|
| 52-week range | 10.05 – 13.55 |
| Return, 1 month / 3 months | −3.6% / −8.1% |
| Return, 1 year / 3 years | −16.5% / −10.8% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 32.7% |
| Worst drawdown (1 year) | -24.5% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nabaltec AG is a German specialty chemicals company based in Schwandorf that makes aluminium hydroxide and alumina-based products. Its materials serve as flame retardants for plastics and cables and as raw materials for ceramics and refractories. The company supplies industrial customers in markets that need mineral-based fillers and technical ceramics, and it develops and produces these specialty chemicals at its own facilities in Germany.
Nabaltec AG trades under the code NTG on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nabaltec AG (NTG) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 10.85 on 23 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 397 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.5% and over the last three months it fell 8.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -6.7% | ||
| From 52-week high | -19.3% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.1% | ||
| 6-month return | 1.8% | ||
| 12-month return, skipping the last month | -13.5% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.5% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | −3.6% |
| 3 months | −8.1% |
| 6 months | +1.8% |
| 1 year | −16.5% |
| 3 years | −10.8% |
| 5 years | −63.2% |
Signals
| 50-day / 200-day average | 11.85 / 11.62 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jun 2026 | EUR 0.2900 |
| 26 Jun 2025 | EUR 0.2900 |
| 26 Jun 2024 | EUR 0.2800 |
| 29 Jun 2023 | EUR 0.2800 |
| 30 Jun 2022 | EUR 0.2500 |
| 1 Jul 2020 | EUR 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.